{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "", "close" : "", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
prnewswire

Strategic Alliance Between Televisa and Genomma Lab

  • Press Release
  • Source: Genomma Lab Internacional, S.A.B. de C.V.
  • On 8:33 am EDT, Friday October 9, 2009

MEXICO CITY, Oct. 9 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. ("Genomma") (BMV: LAB) announced today the successful completion of the Strategic Alliance Agreement with Grupo Televisa, S.A.B. (NYSE: TV; BMV: TLEVISA CPO), which was announced on August 30, 2009, to sell and distribute personal care, cosmetics and over-the-counter pharmaceuticals in the United States and Puerto Rico.

The parties expect to launch operations during the first quarter of 2010.

Company Description:

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing pharmaceutical and personal care products companies in Mexico and has a growing international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. The Company has significantly grown its revenue and profitability through a combination of a successful new product development process, consumer-oriented marketing, a broad retail distribution network and a low-cost, highly flexible operating model.

    IR Contact: Oscar Villalobos
    Tel: +52 (55) 5081-0000 ext. 4250
    E-mail: inversion@genommalab.com

    In New York: i-advize Corporate Communications, Inc.
    Tel: (212) 406-3692
    E-mail: genomma@i-advize.com

Sponsored Links

Copyright © 2009 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.